Abdul J. Sankoh, PhD

Sage Therapeutics, Inc, Cambridge, Massachusetts

JCP
Effect of Zuranolone vs Placebo in MDD
Original Research

February 20, 2023

This phase 3 RCT found significant improvement in depressive symptoms with zuranolone beginning at day 3 of treatment.
Anita H. Clayton, Robert Lasser, Indrani Nandy, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe